FDA appeals e-cigarette ruling
This article was originally published in The Tan Sheet
Executive Summary
FDA Feb. 1 appeals the U.S. District Court for the District of Columbia's decision in January that electronic cigarettes are tobacco products despite the agency's interpretation the products are unapproved drug devices. FDA in July warned consumers about e-cigarettes and stopped shipments from entering the U.S. because tested lots contained toxic materials (1"The Tan Sheet" Jan. 18, 2010, In Brief). In the agency's motion to appeal the Jan. 14 decision, FDA asks the court for "an immediate temporary stay to permit consideration of this stay motion," explaining that the Family Smoking Prevention and Tobacco Control Act excludes under the "tobacco products" definition any item that is a drug, device or combination product under the Food, Drug and Cosmetic Act
You may also be interested in...
Smoking Cessation Claims For E-Cigarettes Draw FDA Warnings
FDA is in discussions with multiple firms about new drug applications for electronic cigarettes as it warns five firms that smoking cessation claims make their e-cigarettes unapproved new drugs.
Federal court lifts import ban on e-cigarettes
The U.S. District Court for the District of Columbia grants electronic cigarette distributors a preliminary injunction that allows them to be classified as tobacco products. The decision overturns FDA's interpretation that the products were unapproved drug devices and agrees with arguments made by law firm Latham & Watkins on behalf of Sottera, a distributor of e-cigarette brand Njoy, according to a Jan. 14 release. FDA in July warned consumers about the e-cigarettes and stopped shipments from entering the U.S. because tested lots contained toxic materials (1"The Tan Sheet" July 27, 2009)